SK
Sanjay Kumar Chawala
About Sanjay Kumar Chawala
Data last updated:
Sanjay Kumar Chawala is a Whole-Time Director at Sai Rk Pharma Private Limited (since 2025). The companies operate in Pharma. Sai Rk Pharma Private Limited reported revenue of ₹87.20 Cr (FY 2026). Earlier, Sanjay Kumar Chawala was a Director at Genix Lifescience Private Limited (2017–2019) and Director at Asterism Pharmaceuticals Private Limited (2017–2020) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sai Rk Pharma Private Limited U46497DL2025PTC448169 | Whole-Time Director | 10 May 2025 | 2025 | ₹87.20 Cr (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Genix Lifescience Private Limited U51909DL2012PTC245635 | Director | 08 Dec 2017 | 2012 | ₹8.94 Cr (FY 2025) | Active |
 Asterism Pharmaceuticals Private Limited U51900DL2016PTC298664 | Director | 12 Jul 2017 | 2016 | ₹1.07 Cr (FY 2025) | Active |
| Synonn Lifesciences Limited U51397DL2008PLC185780 | Director | 12 Dec 2008 | 2008 | ₹1.32 Cr (FY 2019) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Kumar Chawala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manish Kumar | 11135203 | Sai Rk Pharma Private Limited | Director |
| Prateek Chawla | 11102014 | Sai Rk Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Kumar Chawala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Kumar Chawala
Sanjay Kumar Chawala currently holds 1 directorship: Sai Rk Pharma Private Limited (Whole-Time Director, since 10 May 2025, revenue ₹87.20 Cr (FY 2026)).
Sanjay Kumar Chawala was first appointed on 12 Dec 2008 as Director at Synonn Lifesciences Limited. The most recent appointment on record is 10 May 2025 at Sai Rk Pharma Private Limited.
Sanjay Kumar Chawala held 3 earlier board appointments: Genix Lifescience Private Limited (Director, 08 Dec 2017 to 04 Dec 2019); Asterism Pharmaceuticals Private Limited (Director, 12 Jul 2017 to 07 May 2020); Synonn Lifesciences Limited (Director, 12 Dec 2008 to 01 Apr 2009).
The current boards of Sanjay Kumar Chawala's companies include Manish Kumar (Sai Rk Pharma Private Limited), Prateek Chawla (Sai Rk Pharma Private Limited).